CorMedix (CRMD) Enterprise Value (2010 - 2026)
CorMedix (CRMD) posted Enterprise Value of -$155.2 million for Q4 2025, down 174.28% sequentially from -$56.6 million in Q3 2025, and down 200.27% YoY from $154.8 million in Q4 2024.
CorMedix (CRMD) Enterprise Value (2010 - 2026) Analysis & Trends
CorMedix has reported Enterprise Value for 16 years, with the latest figure at -$155.2 million in Q4 2025.
- Quarterly Enterprise Value fell 200.27% year-over-year to -$155.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$155.2 million (down 200.27% YoY) and the FY2025 annual result came in at -$155.2 million, down 200.27% from the prior year.
- Enterprise Value slipped to -$155.2 million in Q4 2025 per CRMD's latest filing, from -$56.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$22.7 million in Q1 2022 and troughed at -$190.7 million in Q2 2025.
- A 5-year average of -$65.9 million and a median of -$57.6 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2021 and 2022: Enterprise Value slumped 42266.88% in 2021, then surged 72.03% in 2022.
- Over 5 years, Enterprise Value stood at -$65.5 million in 2021, then surged by 33.9% to -$43.3 million in 2022, then slumped by 75.7% to -$76.0 million in 2023, then jumped by 32.02% to -$51.7 million in 2024, then tumbled by 200.27% to -$155.2 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$155.2 million, -$56.6 million, and -$190.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | -256.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -256.69 Mn |
| Dec 31, 2025 | -155.20 Mn |
| Sep 30, 2025 | -56.58 Mn |
| Jun 30, 2025 | -190.71 Mn |
| Mar 31, 2025 | -77.50 Mn |
| Dec 31, 2024 | -51.69 Mn |
| Sep 30, 2024 | -46.03 Mn |
| Jun 30, 2024 | -45.61 Mn |
| Mar 31, 2024 | -58.55 Mn |
| Dec 31, 2023 | -76.03 Mn |
| Sep 30, 2023 | -86.59 Mn |
| Jun 30, 2023 | -52.40 Mn |
| Mar 31, 2023 | -25.39 Mn |
| Dec 31, 2022 | -43.27 Mn |
| Sep 30, 2022 | -59.00 Mn |
| Jun 30, 2022 | -22.76 Mn |
| Mar 31, 2022 | -22.70 Mn |
| Dec 31, 2021 | -65.47 Mn |
| Sep 30, 2021 | -28.28 Mn |
| Jun 30, 2021 | -73.23 Mn |